Evaluation of Effect of glycerin suppository in prevention of neonatal jaundice in besat hospital in sanandaj in 2016-17
Phase 1
- Conditions
- neonatal jundice.Neonatal jaundice from other and unspecified causes
- Registration Number
- IRCT20180306038980N1
- Lead Sponsor
- Sanandaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
all of the newborn of besat hospital of sanandaj and referred newborn to that hospital
Exclusion Criteria
under 2500 gr weight
birth before 37th week of pregnancy
positive combs
ABO
FEVER
Fever
GDM
Cephalohematoma
addicted mother
c/s
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Billirubin range. Timepoint: 12,24 and 48 hours and 5 day after birth. Method of measurement: bilicheck instrument.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie glycerin suppository's effect on neonatal jaundice prevention in IRCT20180306038980N1?
How does glycerin suppository compare to standard phototherapy in preventing neonatal jaundice recurrence rates?
Are there specific biomarkers that predict neonatal response to glycerin suppository treatment for jaundice prevention?
What are the potential adverse events associated with glycerin suppository use in neonates and their management strategies?
What combination therapies or alternative compounds show promise alongside glycerin for neonatal jaundice prevention?